In the fast-paced world of the food industry, an increasing number of companies are constantly seeking innovative ways to enhance their marketing and sales strategies. With the advent of cutting-edge ...
The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback